Publications
2024
Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post-hoc analysis of the WARCEF trial.
Ishiguchi, H., Chen, Y., Huang, B., Gue, Y., Correa, E., Homma, S., . . . Abdul-Rahim, A. H. (2024). Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post-hoc analysis of the WARCEF trial.. European journal of clinical investigation, e14360. doi:10.1111/eci.14360
Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines.
Cheang, I., Zhu, X., Huang, J. -Y., Tse, Y. -K., Li, H. -L., Ren, Q. -W., . . . Yiu, K. -H. (2024). Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines.. Cancer, 130(16), 2795-2806. doi:10.1002/cncr.35322
One-year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala-AF Registry.
Calvert, P., Chen, Y., Gue, Y., Gupta, D., Azariah, J. L., George Koshy, A., . . . Kerala AF Registry Investigators. (2024). One-year outcomes of rate versus rhythm control of atrial fibrillation in the Kerala-AF Registry.. Journal of arrhythmia, 40(4), 822-829. doi:10.1002/joa3.13059
The cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early estrogen receptor-positive breast cancer: a systematic review
Gue, Y., Lau, D., Lip, G., Shantsila, A., & Palmieri, C. (n.d.). The cardiovascular and metabolic effects of ovarian suppression in combination with tamoxifen or an aromatase inhibitor as adjuvant therapy for early estrogen receptor-positive breast cancer: a systematic review. Archives of Medical Science. doi:10.5114/aoms/190743
Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.
Bucci, T., Gue, Y., Dobson, R., Palmieri, C., Pignatelli, P., & Lip, G. Y. H. (2024). Statin use is associated with a lower risk of all-cause death in patients with breast cancer treated with anthracycline containing regimens: a global federated health database analysis.. Clinical and experimental medicine, 24(1), 124. doi:10.1007/s10238-024-01395-z
Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort.
Chen, Y., Gue, Y., Banach, M., Mikhailidis, D., Toth, P. P., Gierlotka, M., . . . LIPIDOGRAM Investigators. (2024). Phenotypes of Polish primary care patients using hierarchical clustering: Exploring the risk of mortality in the LIPIDOGEN2015 study cohort.. European journal of clinical investigation, e14261. doi:10.1111/eci.14261
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.
Chen, Y., Gue, Y., McDowell, G., Gorog, D. A., & Lip, G. Y. H. (2024). Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke.. Minerva medica, 115(3), 364-379. doi:10.23736/s0026-4806.24.09133-x
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.
Suh, J. -W., Memtsas, V., Gue, Y. X., Cho, H. -W., Lee, W., Kang, S. -H., & Gorog, D. A. (2024). Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects.. Thrombosis and haemostasis, 124(6), 501-516. doi:10.1055/s-0043-1777794
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.
Gue, Y., Bloomfield, D., Freedholm, D., & Lip, G. Y. H. (2024). Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation.. Journal of clinical medicine, 13(8), 2277. doi:10.3390/jcm13082277
Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study.
Gue, Y. X., Memtsas, V., Kanji, R., Wellsted, D. M., Busby, A., Smith, M., . . . Gorog, D. A. (2024). Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study.. Thrombosis research, 236, 144-154. doi:10.1016/j.thromres.2024.02.030
The Reply.
Gue, Y., & Lip, G. Y. H. (2024). The Reply.. The American journal of medicine, 137(3), e61. doi:10.1016/j.amjmed.2023.11.024
Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?
Gue, Y. X., & Lip, G. Y. H. (2024). Hematologic Malignancies and Increased Cardiovascular Risk-Can More Be Done to Mitigate?. The American journal of cardiology, 213, 182-183. doi:10.1016/j.amjcard.2023.12.039
Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.
Chen, Y., Gue, Y., Calvert, P., Gupta, D., McDowell, G., Azariah, J. L., . . . KERALA-AF Registry & APHRS-AF Registry Investigators joint senior authors. (2024). Predicting stroke in Asian patients with atrial fibrillation using machine learning: A report from the KERALA-AF registry, with external validation in the APHRS-AF registry.. Current problems in cardiology, 49(4), 102456. doi:10.1016/j.cpcardiol.2024.102456
2023
Increased risk of venous thromboembolism in patients with gastrointestinal disorders
Gue, Y. X., & Lip, G. Y. H. (2023). Increased risk of venous thromboembolism in patients with gastrointestinal disorders. AMERICAN JOURNAL OF HEMATOLOGY. doi:10.1002/ajh.27140
Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?
Gue, Y. X., & Lip, G. Y. H. (2023). Complete revascularization in elderly patients with myocardial infarction-a safe, effective, and necessary strategy?. Cell reports. Medicine, 4(11), 101284. doi:10.1016/j.xcrm.2023.101284
Point-of-care biomarkers of thrombotic status predict spontaneous reperfusion in ST-segment elevation MI and clinical outcomes
Kanji, R., Gue, Y. X., Memtsas, V., Spencer, N. H., & Gorog, D. A. (2023). Point-of-care biomarkers of thrombotic status predict spontaneous reperfusion in ST-segment elevation MI and clinical outcomes. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.1373
Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis
Bucci, T., Gue, Y., Dobson, R., Palmieri, C., Pignatelli, P., Cross, M., & Lip, G. Y. H. (2023). Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.2876
Thrombotic profile of East Asian and Western ACS patients and relationship to cardiovascular outcomes
Suh, J. W., Memstas, V., Gue, Y. X., Cho, H. Y., Lee, W., Kang, S. H., & Gorog, D. A. (2023). Thrombotic profile of East Asian and Western ACS patients and relationship to cardiovascular outcomes. European Heart Journal, 44(Supplement_2). doi:10.1093/eurheartj/ehad655.1368
Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
Gue, Y., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (2023). Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.. The American journal of medicine, 136(11), 1099-1108.e2. doi:10.1016/j.amjmed.2023.07.019
Hypertension and atrial fibrillation: Closing a virtuous circle
Gue, Y. X., & Lip, G. Y. H. (2023). Hypertension and atrial fibrillation: Closing a virtuous circle. In Advances in Surgical and Medical Specialties (pp. 191-195).
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction
Kanji, R., Gue, Y. X., Memtsas, V., Spencer, N. H., & Gorog, D. A. (2023). Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81(19), 1918-1932. doi:10.1016/j.jacc.2023.03.388
Meta-analysis Comparing long-term clinical outcomes of percutaneous coronary intervention versus no intervention in patients with chronic total occlusion
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., & Egred, M. (2023). Meta-analysis Comparing long-term clinical outcomes of percutaneous coronary intervention versus no intervention in patients with chronic total occlusion. HEART VIEWS, 24(2), 104-108. doi:10.4103/heartviews.heartviews_82_22
Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and Approaches to Management
Farag, M., Peverelli, M., Spinthakis, N., Gue, Y. X., Egred, M., & Gorog, D. A. (2023). Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and Approaches to Management. CARDIOVASCULAR DRUGS AND THERAPY, 37(1), 169-180. doi:10.1007/s10557-021-07226-7
2022
Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study
Harrison, S. L., Buckley, B. J. R., Zheng, Y., Hill, A., Hlaing, T., Davies, R., . . . Jones, I. (2022). Evaluation of Huawei Smart Wearables for Detection of Atrial Fibrillation in Patients Following Ischaemic Stroke: The Liverpool-Huawei Stroke Study. American Heart Journal. doi:10.1016/j.ahj.2022.12.004
MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)
Gue, Y. X., Correa, E., Thompson, J. L. P., Homma, S., Qian, M., & Lip, G. Y. H. (n.d.). MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint). JMIR AI. doi:10.2196/43822
MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction
Kanji, R., Gue, Y. X., Farag, M. F., Spencer, N. H., Mutch, N. J., & Gorog, D. A. (2022). Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. JACC-BASIC TO TRANSLATIONAL SCIENCE, 7(11), 1069-1082. doi:10.1016/j.jacbts.2022.05.007
Stroke prevention in atrial fibrillation
Lip, G. Y. H., Gue, Y., Zhang, J., Chao, T. -F., Calkins, H., & Potpara, T. (2022). Stroke prevention in atrial fibrillation. TRENDS IN CARDIOVASCULAR MEDICINE, 32(8), 501-510. doi:10.1016/j.tcm.2021.10.001
Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction
Kanji, R., Gue, Y. X., Farag, M. F., Mutch, N. J., & Gorog, D. A. (2022). Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac157.034
Cardiovascular and metabolic effects of ovarian suppression as adjuvant therapy for early breast cancer: a systematic review and meta-analysis
Gue, Y. (2022). Cardiovascular and metabolic effects of ovarian suppression as adjuvant therapy for early breast cancer: a systematic review and meta-analysis. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac157.021
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?. CIRCULATION, 146(16), 1207-1209. doi:10.1161/CIRCULATIONAHA.122.061987
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. THROMBOSIS AND HAEMOSTASIS, 122(10), 1625-1652. doi:10.1055/s-0042-1750385
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?
Gue, Y. X., Gorog, D. A., & Lip, G. Y. H. (2022). Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease Does Less Mean More?. JAMA CARDIOLOGY, 7(8), 794-795. doi:10.1001/jamacardio.2022.1572
Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications
Nelson, J. A., Gue, Y. X., Christensen, J. M., Lip, G. Y. H., & Ramakrishna, H. (2022). Analysis of the ESC/EACTS 2020 Atrial Fibrillation Guidelines With Perioperative Implications. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(7), 2177-2195. doi:10.1053/j.jvca.2021.05.011
A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R
Gue, Y. X., Kanji, R., Wellsted, D., Srinivasan, M., Wyatt, S., & Gorog, D. (2022). A randomised trial on modulating endogenous fibrinolysis in patients with acute coronary syndrome VaLiDate-R. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.215
Diurnal Variation in thrombolytic status in patients presenting with STEMI
Gue, Y. X., Farag, M., Spinthakis, N., Wellsted, D., & Gorog, D. (2022). Diurnal Variation in thrombolytic status in patients presenting with STEMI. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.050
Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers
Gue, Y., Memtsas, V., Kanji, R., & Gorog, D. (2022). Diurnal variation in thrombotic and fibrinolytic status in healthy volunteers. Cardiovascular Research, 118(Supplement_1). doi:10.1093/cvr/cvac066.217
Does targeted temperature management increase the risk of stent thrombosis in survivors of out-of-hospital cardiac arrest? A single centre experience
Kanji, R., Gue, Y. X., Saw, A. M., Shahid, M. Q., & Gorog, D. A. (2022). Does targeted temperature management increase the risk of stent thrombosis in survivors of out-of-hospital cardiac arrest? A single centre experience. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.218
Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro
Gue, Y. X., Spinthakis, N., Topping, W., Patel, J., Baydoun, A., Farrington, K., . . . Gorog, D. (2022). Relationship between coronary stenosis severity and high shear thrombosis assessment in vitro. In CARDIOVASCULAR RESEARCH Vol. 118. doi:10.1093/cvr/cvac066.216
Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2022). Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 52(6). doi:10.1111/eci.13754
LONG TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION: A META-ANALYSIS OF RANDOMISED TRIALS
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., & Egred, M. (2022). LONG TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION: A META-ANALYSIS OF RANDOMISED TRIALS. In HEART Vol. 108 (pp. A36-A38). doi:10.1136/heartjnl-2022-BCS.51
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini, J. P., Caso, V., Connolly, S. J., Fox, K. A. A., Oldgren, J., Jones, W. S., . . . PACIFIC-AF Investigators. (2022). Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.. Lancet (London, England), 399(10333), 1383-1390. doi:10.1016/s0140-6736(22)00456-1
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Gorog, D. A., Gue, Y. X., Chao, T. -F., Fauchier, L., Ferreiro, J. L., Huber, K., . . . Lip, G. Y. H. (2022). Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE. doi:10.1093/europace/euac020
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2022). Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. THROMBOSIS AND HAEMOSTASIS, 122(03), 406-414. doi:10.1055/a-1515-9630
Diurnal and weekly variation in thrombotic and fibrinolytic status in healthy individuals
Memtsas, V. P., Gue, Y. X., Kanji, R., & Gorog, D. A. (2022). Diurnal and weekly variation in thrombotic and fibrinolytic status in healthy individuals. In CARDIOVASCULAR RESEARCH Vol. 118. Retrieved from https://www.webofscience.com/
META-ANALYSIS COMPARING LONG-TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION
Ibrahem, A., Farag, M., Gue, Y. X., Spinthakis, N., Al-Atta, A., Elzein, H., & Egred, M. (2022). META-ANALYSIS COMPARING LONG-TERM CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION VERSUS NO INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 79 (pp. 846). Retrieved from https://www.webofscience.com/
2021
Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study
Gue, Y. X., Bisson, A., Bodin, A., Herbert, J., Lip, G. Y. H., & Fauchier, L. (2021). Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 8(12). doi:10.3390/jcdd8120177
Crizanlizumab A CRITICAL Drug During a CRITICAL Time?
Gue, Y. X., Pula, G., & Lip, G. Y. H. (2021). Crizanlizumab A CRITICAL Drug During a CRITICAL Time?. JACC-BASIC TO TRANSLATIONAL SCIENCE, 6(12), 946-947. doi:10.1016/j.jacbts.2021.10.013
Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.
Gue, Y. X., El-Bouri, W. K., & Lip, G. Y. H. (2021). Photoplethysmography rhythm interpretation: an essential skill in an era of novel technologies.. European heart journal. Digital health, 2(3), 361-362. doi:10.1093/ehjdh/ztab068
Case report of subacute presentation of tricuspid valve thrombus complicated by widespread bilateral pulmonary emboli: a multifactorial aetiology
Myslivecek, L., Gue, Y., & Vasiliadis, I. (2021). Case report of subacute presentation of tricuspid valve thrombus complicated by widespread bilateral pulmonary emboli: a multifactorial aetiology. EUROPEAN HEART JOURNAL-CASE REPORTS, 5(8). doi:10.1093/ehjcr/ytab282
Myocardial Ischaemia And Angina In Men
Gorog, D. A., & Gue, Y. X. (2021). Myocardial Ischaemia And Angina In Men. In Men's Health (pp. 166-173). CRC Press. doi:10.1201/9780429347238-20
'Rise of the machines': the next frontier in individualized medicine.
El-Bouri, W. K., Gue, Y., & Lip, G. Y. H. (2021). 'Rise of the machines': the next frontier in individualized medicine.. Cardiovascular research. doi:10.1093/cvr/cvab220
Hypertension and atrial fibrillation: Closing a virtuous circle
Gue, Y. X., & Lip, G. Y. H. (2021). Hypertension and atrial fibrillation: Closing a virtuous circle. PLOS MEDICINE, 18(6). doi:10.1371/journal.pmed.1003598
Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?
Kotalczyk, A., Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2021). Current trends in the use of anticoagulant pharmacotherapy in the United Kingdom are changes on the horizon?. EXPERT OPINION ON PHARMACOTHERAPY, 22(8), 1061-1070. doi:10.1080/14656566.2021.1879050
The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients
Romiti, G. F., Pastori, D., Rivera-Caravaca, J. M., Ding, W. Y., Gue, Y. X., Menichelli, D., . . . Proietti, M. (2021). The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients. EP Europace, 23(Supplement_3). doi:10.1093/europace/euab116.290
Fibrinolysis in Platelet Thrombi
Kanji, R., Gue, Y. X., Memtsas, V., & Gorog, D. A. (2021). Fibrinolysis in Platelet Thrombi. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(10). doi:10.3390/ijms22105135
Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?
Gue, Y. X., Ding, W. Y., Lip, G. Y. H., & Gorog, D. A. (2021). Assessment of endogenous fibrinolysis in clinical practice using novel tests: ready for clinical roll-out?. SN APPLIED SCIENCES, 3(5). doi:10.1007/s42452-021-04517-4
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 (vol 10, 21379, 2020)
Gue, Y. X., Tennyson, M., Gao, J., Ren, S., Kanji, R., & Gorog, D. A. (2021). Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 (vol 10, 21379, 2020). SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-87439-w
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events
Gue, Y. X., & Lip, G. Y. H. (2021). In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events. ANNALS OF INTERNAL MEDICINE, 174(4), JC43. doi:10.7326/ACPJ202104200-043
Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival
GUE, Y. X., ADATIA, K., KANJI, R., POTPARA, T., LIP, G. Y. H., & GOROG, D. A. (2021). Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival. AMERICAN HEART JOURNAL, 234, 31-41. doi:10.1016/j.ahj.2020.12.011
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review
Jenner, W. J., Kanji, R., Mirsadraee, S., Gue, Y. X., Price, S., Prasad, S., & Gorog, D. A. (2021). Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 51(3), 595-607. doi:10.1007/s11239-021-02394-7
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis
Gue, Y. X., Spinthakis, N., Egred, M., Gorog, D. A., & Farag, M. (2021). Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis. AMERICAN JOURNAL OF CARDIOLOGY, 142, 147-151. doi:10.1016/j.amjcard.2020.12.014
Precision Treatment in ACS-Role of Assessing Fibrinolysis
Gue, Y. X., Jeong, Y. -H., Farag, M., Spinthakis, N., & Gorog, D. A. (2021). Precision Treatment in ACS-Role of Assessing Fibrinolysis. JOURNAL OF CLINICAL MEDICINE, 10(5). doi:10.3390/jcm10050929
Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting
Farag, M., Gue, Y. X., Brilakis, E. S., & Egred, M. (2021). Meta-analysis Comparing Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Grafting. AMERICAN JOURNAL OF CARDIOLOGY, 140, 47-54. doi:10.1016/j.amjcard.2020.10.062
2020
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19
Gue, Y. X., Tennyson, M., Gao, J., Ren, S., Kanji, R., & Gorog, D. A. (2020). Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. SCIENTIFIC REPORTS, 10(1). doi:10.1038/s41598-020-78505-w
Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways
Gue, Y. X., Potpara, T. S., & Lip, G. Y. H. (2020). Detection of Atrial Fibrillation on Stroke Units: Look Harder, Look Longer, Look in More Sophisticated Ways. CEREBROVASCULAR DISEASES, 49(6), 656-658. doi:10.1159/000512205
Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS
Kanji, R., Gue, Y. X., Dinarvand, D., Farag, M. Q., & Gorog, D. A. (2020). Assessment of endogenous fibrinolysis using a point-of-care assay to identify increased cardiovascular risk in patients with diabetes and ACS. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 1540). Retrieved from https://www.webofscience.com/
Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI
Gue, Y., Mutch, N., Kanji, R., Farag, M., & Gorog, D. A. (2020). Correlation between plasma clot properties, thrombin generation and whole blood fibrinolytic assays in patients presenting with STEMI. European Heart Journal, 41(Supplement_2). doi:10.1093/ehjci/ehaa946.1551
No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA
Kanji, R., Gue, Y. X., Dinarvand, D., & Gorog, D. A. (2020). No difference in thrombotic profile of patients with ACS with obstructive CAD and MINOCA. In EUROPEAN HEART JOURNAL Vol. 41 (pp. 1541). Retrieved from https://www.webofscience.com/
Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest
Gue, Y. X., Sayers, M., Whitby, B. T., Kanji, R., Adatia, K., Smith, R., . . . Gorog, D. A. (2020). Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest. AMERICAN JOURNAL OF MEDICINE, 133(11), 1328-1335. doi:10.1016/j.amjmed.2020.03.046
TCT CONNECT-251 Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis
Gue, Y., Brilakis, E., Egred, M., & Farag, M. (2020). TCT CONNECT-251 Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology, 76(17), B111. doi:10.1016/j.jacc.2020.09.268
Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19
Gue, Y. X., Kanji, R., Markides, V., & Gorog, D. A. (2020). Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19. AMERICAN JOURNAL OF CARDIOLOGY, 130, 161-162. doi:10.1016/j.amjcard.2020.06.002
Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19
Gue, Y. X., & Gorog, D. A. (2020). Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. EUROPEAN HEART JOURNAL, 41(33), 3198-3199. doi:10.1093/eurheartj/ehaa534
Thrombosis Risk with Transcatheter Aortic Valve Replacement
Kanji, R., Mirsadraee, S., Prasad, S., Gue, Y. X., Panoulas, V., & Gorog, D. A. (2020). Thrombosis Risk with Transcatheter Aortic Valve Replacement. STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 4(5), 349-359. doi:10.1080/24748706.2020.1797256
Insights from multimodality imaging in a case of giant true coronary aneurysm treated percutaneously with polytetrafluoroethylene covered stent.
Menahalli Palleda, G., Gupta, M. D., & Batra, V. (2020). Insights from multimodality imaging in a case of giant true coronary aneurysm treated percutaneously with polytetrafluoroethylene covered stent.. European heart journal. Case reports, 4(4), 1-2. doi:10.1093/ehjcr/ytaa123
CLINICAL CODING ERRORS IN ELECTIVE DEVICE IMPLANTATION COSTING
Kiberu, Y., Ara, F., Gue, Y. X., & Szygula, J. (2020). CLINICAL CODING ERRORS IN ELECTIVE DEVICE IMPLANTATION COSTING. In HEART Vol. 106 (pp. A58-A59). doi:10.1136/heartjnl-2020-BCS.77
Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis
Gue, Y. X., Spinthakis, N., Farag, M., Kubica, J., Siller-Matula, J. M., Srinivasan, M., & Gorog, D. A. (2020). Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis. CLINICAL PHARMACOLOGY & THERAPEUTICS, 108(1), 54-62. doi:10.1002/cpt.1798
Myocardial infarction with non-obstructive coronary arteries in young women presenting with ST-segment elevation myocardial infarction: a case series
Kanji, R., Dinarvand, D., Gue, Y. X., & Gorog, D. A. (n.d.). Myocardial infarction with non-obstructive coronary arteries in young women presenting with ST-segment elevation myocardial infarction: a case series. Medical Research Journal. doi:10.5603/mrj.a2020.0006
Fatal heart block fromintentional yew tree (<i>Taxus baccata</i>) ingestion: a case report
Natasha, G., Chan, M., Gue, Y. X., & Gorog, D. A. (2020). Fatal heart block fromintentional yew tree (<i>Taxus baccata</i>) ingestion: a case report. EUROPEAN HEART JOURNAL-CASE REPORTS, 4(1). doi:10.1093/ehjcr/ytz226
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
Gue, Y. X., Kanji, R., Wellsted, D. M., Srinivasan, M., Wyatt, S., & Gorog, D. A. (2020). Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 49(2), 192-198. doi:10.1007/s11239-019-02014-5
MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment
Gue, Y. X., Kanji, R., Gati, S., & Gorog, D. A. (2020). MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment. EUROPEAN CARDIOLOGY REVIEW, 15, 109-116. doi:10.15420/ecr.2019.13
Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis
Gue, Y., Brilakis, E., Egred, M., & Farag, M. (2020). Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-Analysis. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 76 (pp. B111). Retrieved from https://www.webofscience.com/
2019
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation
Gue, Y. X., Inoue, N., Spinthakis, N., Takei, A., Takahara, H., Otsui, K., . . . Gorog, D. A. (2019). Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(22), 2822-2824. doi:10.1016/j.jacc.2019.01.079
MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort
Gue, Y. X., Corballis, N., Ryding, A., Kaski, J. C., & Gorog, D. A. (2019). MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 48(4), 533-538. doi:10.1007/s11239-019-01919-5
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
Hausenloy, D. J., Kharbanda, R. K., Møller, U. K., Ramlall, M., Aarøe, J., Butler, R., . . . CONDI-2/ERIC-PPCI Investigators. (2019). Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.. Lancet (London, England), 394(10207), 1415-1424. doi:10.1016/s0140-6736(19)32039-2
P327Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). P327Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. European Heart Journal, 40(Supplement_1). doi:10.1093/eurheartj/ehz747.0162
P4744Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis
Gue, Y. X., Spinthakis, N., Markides, V., Wong, T., & Gorog, D. (2019). P4744Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis. European Heart Journal, 40(Supplement_1). doi:10.1093/eurheartj/ehz745.1120
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
Spinthakis, N., Gue, Y., Farag, M., Srinivasan, M., Wellsted, D., Arachchillage, D. R. J., . . . Gorog, D. A. (2019). Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation. EUROPACE, 21(9), 1297-1306. doi:10.1093/europace/euz176
A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome
Gue, Y. X., Prasad, S., Isenberg, D., & Gorog, D. A. (2019). A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. EUROPEAN HEART JOURNAL-CASE REPORTS, 3(2). doi:10.1093/ehjcr/ytz041
155 Relationship between pre-procedural platelet reactivity and inflammatory markers to cardiac outcomes in patients undergoing PPCI
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). 155 Relationship between pre-procedural platelet reactivity and inflammatory markers to cardiac outcomes in patients undergoing PPCI. In Acute Coronary Syndromes (pp. A129-A130). BMJ Publishing Group Ltd and British Cardiovascular Society. doi:10.1136/heartjnl-2019-bcs.152
Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
Spinthakis, N., Gue, Y., Farag, M., Ren, G., Srinivasan, M., Baydoun, A., & Gorog, D. A. (2019). Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 47(3), 392-395. doi:10.1007/s11239-018-01799-1
Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study
Farag, M., Spinthakis, N., Gue, Y. X., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2019). Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. EUROPEAN HEART JOURNAL, 40(3), 295-305. doi:10.1093/eurheartj/ehy656
Effect of P2Y<sub>12</sub> inhibitors on thrombus stability and endogenous fibrinolysis
Spinthakis, N., Farag, M., Gue, Y. X., Srinivasan, M., Wellsted, D. M., & Gorog, D. A. (2019). Effect of P2Y<sub>12</sub> inhibitors on thrombus stability and endogenous fibrinolysis. THROMBOSIS RESEARCH, 173, 102-108. doi:10.1016/j.thromres.2018.11.023
Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis
Gue, Y. X., Spinthakis, N., Markides, V., Wong, T., & Gorog, D. (2019). Patients with atrial fibrillation exhibit a systemic prothrombotic state attributable to impaired endogenous fibrinolysis. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 2948). Retrieved from https://www.webofscience.com/
Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention
Adatia, K., Farag, M., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention. In EUROPEAN HEART JOURNAL Vol. 40 (pp. 125). Retrieved from https://www.webofscience.com/
Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction
Adatia, K., Farag, M. F., Gue, Y. X., Srinivasan, M., & Gorog, D. A. (2019). Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction. THROMBOSIS AND HAEMOSTASIS, 119(11), 1785-1794. doi:10.1055/s-0039-1695007
2018
2151Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study
Farag, M., Spinthakis, N., Gue, Y., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2018). 2151Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy565.2151
P4651Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort
Gue, Y. X., Farag, M., Spinthakis, N., Anwar, M., Gorog, D. A., & Srinivasan, M. (2018). P4651Incidence of MINOCA in patients presenting with STEMI for PPCI- applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort. European Heart Journal, 39(suppl_1). doi:10.1093/eurheartj/ehy563.p4651
A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevationmyocardial infarction caused by a mediastinal mass
Gue, Y. X., Anwar, M., & Gorog, D. A. (2018). A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevationmyocardial infarction caused by a mediastinal mass. EUROPEAN HEART JOURNAL-CASE REPORTS, 2(1). doi:10.1093/ehjcr/yty008
Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study
Farag, M., Spinthakis, N., Gue, Y., Srinivasan, M., Sullivan, K., Wellsted, D., & Gorog, D. A. (2018). Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 430-431). Retrieved from https://www.webofscience.com/
Incidence of MINOCA in patients presenting with STEMI for PPCI-applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort
Gue, Y. X., Farag, M., Spinthakis, N., Anwar, M., Gorog, D. A., & Srinivasan, M. (2018). Incidence of MINOCA in patients presenting with STEMI for PPCI-applying the criteria of the ESC working group position paper on MINOCA to a contemporary cohort. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 960). Retrieved from https://www.webofscience.com/
2017
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease
Spinthakis, N., Farag, M., Gorog, D. A., Prasad, A., Mahmood, H., Gue, Y., . . . Srinivasan, M. (2017). Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease. INTERNATIONAL JOURNAL OF CARDIOLOGY, 249, 101-106. doi:10.1016/j.ijcard.2017.09.156
An uncommon manifestation of shock: Takotsubo syndrome
Gue, Y. X., Bhandari, S. S., & Ahamed, M. (2017). An uncommon manifestation of shock: Takotsubo syndrome. ECHO RESEARCH AND PRACTICE, 4(4), K41-K45. doi:10.1530/ERP-17-0040
An Unusual Case of Thromboembolic Stroke - Silent Myocardial Infarction from Spontaneous Coronary Artery Dissection
Gue, Y. X. (n.d.). An Unusual Case of Thromboembolic Stroke - Silent Myocardial Infarction from Spontaneous Coronary Artery Dissection. Angiology & Vascular Surgery, 2(1), 1-3. doi:10.24966/avs-7397/100006
Critical aortic stenosis presenting as STEMI
Gue, Y. X., Bhandari, S. S., & Kelly, D. J. (2017). Critical aortic stenosis presenting as STEMI. ECHO RESEARCH AND PRACTICE, 4(3), K7-K10. doi:10.1530/ERP-17-0017
Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation
Gue, Y. X., & Gorog, D. A. (2017). Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18(9). doi:10.3390/ijms18091850
2014
Fosfomycin - is a second dose needed?
Gue, Y. X., & Kidder, D. (2014). Fosfomycin - is a second dose needed?. In SCOTTISH MEDICAL JOURNAL Vol. 59 (pp. E24-E25). Retrieved from https://www.webofscience.com/